The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
6
- 1
Miessau, Matthew James
Senior Associate, Venture Capital born in July 1988Individual (2 offsprings)Officer
2022-02-15 ~ nowOF - Director → CIF 0 - 2
Smith, Godfrey, Professor
Professor born in February 1957Individual (2 offsprings)Officer 2012-07-04 ~ nowOF - Director → CIF 0 - 3
Henderson, Richard David
Director born in April 1966Individual (33 offsprings)Officer 2019-02-25 ~ nowOF - Director → CIF 0 - 4
Johnston, Alan Mcdougall
Director born in January 1953Individual (2 offsprings)Officer 2015-08-01 ~ nowOF - Director → CIF 0 - 5
Dunlop, Andrew Sinclair
Fund Manager born in March 1972Individual (8 offsprings)Officer 2015-03-20 ~ nowOF - Director → CIF 0 - 6ROCK SPRING VPM-UK, LLP - 2014-01-27ROCK SPRING VMP-UK, LLP - 2012-05-09
137a, George Street, EdinburghDissolved Corporate (3 parents, 1 offspring)Person with significant control 2016-04-06 ~ dissolvedPE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased
8
- 1
Craig, Margaret Anne, Dr
Lecturer/Academic born in August 1971Individual (1 offspring)Officer 2012-07-04 ~ 2016-07-13OF - Director → CIF 0 - 2
Finan, Peter Michael, Dr
Director born in July 1967Individual (16 offsprings)Officer 2015-07-29 ~ 2022-02-15OF - Director → CIF 0 - 3
Beaumont, Steven Peter, Professor
Vice-Principal Of Research & Enterprise born in February 1952Individual (15 offsprings)Officer 2012-07-04 ~ 2015-03-20OF - Director → CIF 0 - 4
Rose, Kenneth Charles
Solicitor born in October 1963Individual (32 offsprings)Officer 2012-03-07 ~ 2012-07-04OF - Director → CIF 0 - 5
Wardhaugh, Christopher Thomas
Director born in February 1970Individual (9 offsprings)Officer 2015-03-20 ~ 2018-11-02OF - Director → CIF 0 - 6
D.W. DIRECTOR 1 LIMITED
- nowCOMLAW DIRECTOR LIMITED - 2000-11-064th, Floor, Saltire Court 20 Castle Terrace, Edinburgh, Lothian, United KingdomDissolved Corporate (3 parents, 34 offsprings)Officer2012-03-07 ~ 2012-07-04PE - Director → CIF 0 - 7
IP2IPO SERVICES LIMITED
- nowIP2IPO ACQUISITIONS LIMITED - 2006-04-2824, Cornhill, London, UkActive Corporate (4 parents, 100 offsprings)Officer2012-09-29 ~ 2013-10-09PE - Director → CIF 0 - 84th, Floor, Saltire Court 20 Castle Terrace, Edinburgh, Lothian, United KingdomDissolved Corporate (3 parents, 84 offsprings)Officer2012-03-07 ~ 2012-07-04PE - Director → CIF 02012-03-07 ~ 2012-07-04PE - Secretary → CIF 0
Company in focus
CLYDE BIOSCIENCES LIMITED
Previous name
DUNWILCO (1739) LIMITED - 2012-07-19
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
855 GBP2024-07-31
1,569 GBP2023-07-31
Property, Plant & Equipment
0 GBP2024-07-31
339 GBP2023-07-31
Fixed Assets - Investments
1 GBP2024-07-31
1 GBP2023-07-31
Debtors
Current
113,369 GBP2024-07-31
120,325 GBP2023-07-31
Cash at bank and in hand
164,761 GBP2024-07-31
228,223 GBP2023-07-31
Creditors
Non-current
-1,007,855 GBP2024-07-31
-778,237 GBP2023-07-31
Net Assets/Liabilities
-1,680,195 GBP2024-07-31
-1,542,172 GBP2023-07-31
Equity
Called up share capital
66 GBP2024-07-31
66 GBP2023-07-31
Share premium
1,987,145 GBP2024-07-31
1,987,145 GBP2023-07-31
Retained earnings (accumulated losses)
-3,667,406 GBP2024-07-31
-3,529,383 GBP2023-07-31
Equity
-1,680,195 GBP2024-07-31
-1,542,172 GBP2023-07-31
Average Number of Employees
92023-08-01 ~ 2024-07-31
72022-08-01 ~ 2023-07-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
7,141 GBP2024-07-31
7,141 GBP2023-07-31
Intangible Assets - Gross Cost
7,141 GBP2024-07-31
7,141 GBP2023-07-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
6,286 GBP2024-07-31
5,572 GBP2023-07-31
Intangible Assets - Accumulated Amortisation & Impairment
6,286 GBP2024-07-31
5,572 GBP2023-07-31
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
714 GBP2023-08-01 ~ 2024-07-31
Intangible Assets - Increase From Amortisation Charge for Year
714 GBP2023-08-01 ~ 2024-07-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
855 GBP2024-07-31
1,569 GBP2023-07-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
299,156 GBP2024-07-31
299,156 GBP2023-07-31
Computers
65,445 GBP2024-07-31
65,445 GBP2023-07-31
Property, Plant & Equipment - Gross Cost
364,601 GBP2024-07-31
364,601 GBP2023-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
299,156 GBP2024-07-31
299,156 GBP2023-07-31
Computers
65,445 GBP2024-07-31
65,106 GBP2023-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
364,601 GBP2024-07-31
364,262 GBP2023-07-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
0 GBP2023-08-01 ~ 2024-07-31
Computers
339 GBP2023-08-01 ~ 2024-07-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
339 GBP2023-08-01 ~ 2024-07-31
Property, Plant & Equipment
Plant and equipment
0 GBP2024-07-31
0 GBP2023-07-31
Computers
0 GBP2024-07-31
339 GBP2023-07-31
Investments in Subsidiaries
Cost valuation
1 GBP2024-07-31
1 GBP2023-07-31
Investments in Subsidiaries
1 GBP2024-07-31
1 GBP2023-07-31
Trade Debtors/Trade Receivables
Current
82,538 GBP2024-07-31
75,250 GBP2023-07-31
Other Debtors
Current
30,831 GBP2024-07-31
45,075 GBP2023-07-31
Trade Creditors/Trade Payables
Current
36,396 GBP2024-07-31
40,152 GBP2023-07-31
Other Creditors
Current
906,825 GBP2024-07-31
1,066,335 GBP2023-07-31
Non-current
1,007,855 GBP2024-07-31
778,237 GBP2023-07-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
218,600 shares2024-07-31
Par Value of Share
Class 1 ordinary share
0.0001 GBP2023-08-01 ~ 2024-07-31
Nominal value of allotted share capital
Class 1 ordinary share
22 GBP2023-08-01 ~ 2024-07-31
22 GBP2022-08-01 ~ 2023-07-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
444,638 shares2024-07-31
Par Value of Share
Class 2 ordinary share
0.0001 GBP2023-08-01 ~ 2024-07-31
Nominal value of allotted share capital
Class 2 ordinary share
44 GBP2023-08-01 ~ 2024-07-31
44 GBP2022-08-01 ~ 2023-07-31
CLYDE BIOSCIENCES LIMITED
InfoDUNWILCO (1739) LIMITED - 2012-07-19Registered number SC418838Biocity Scotland, Bo'ness Road, Motherwell, Lanarkshire ML1 5UHPrivate Limited Company incorporated on 2012-03-07 (13 years 7 months). The company status is Active.The last date of confirmation statement was made at 2025-02-09CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 24 April 2025 and
licensed under the Open Government Licence v3.0.